Cargando…

Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools

BACKGROUND: The survival rate of head and neck squamous cell carcinoma (HNSCC) patients with secondary primary malignancy (SPM) showed no significant improvement for decades, however, the impact of advances in diagnostic tools is rarely mentioned. This study investigated the clinical characteristic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shih-Wei, Chan, Leong-Perng, Wang, Ling-Feng, Wu, Che-Wei, Lin, Sheng-Hsuan, Huang, Tzu-Yen, Lee, Ka-Wo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846538/
https://www.ncbi.nlm.nih.gov/pubmed/35167611
http://dx.doi.org/10.1371/journal.pone.0263773
_version_ 1784651866312802304
author Wang, Shih-Wei
Chan, Leong-Perng
Wang, Ling-Feng
Wu, Che-Wei
Lin, Sheng-Hsuan
Huang, Tzu-Yen
Lee, Ka-Wo
author_facet Wang, Shih-Wei
Chan, Leong-Perng
Wang, Ling-Feng
Wu, Che-Wei
Lin, Sheng-Hsuan
Huang, Tzu-Yen
Lee, Ka-Wo
author_sort Wang, Shih-Wei
collection PubMed
description BACKGROUND: The survival rate of head and neck squamous cell carcinoma (HNSCC) patients with secondary primary malignancy (SPM) showed no significant improvement for decades, however, the impact of advances in diagnostic tools is rarely mentioned. This study investigated the clinical characteristic of HNSCC with SPM over a 27-year period especially from the perspective of diagnostic tools. METHODS: This study evaluated 157 HNSCC patients with SPM. The patients were divided into two groups according to the time of SPM diagnosis (Group A:1992–2003; Group B: 2004–2014). Age, gender, stage of first primary malignancy (FPM), SPM interval, overall survival, and disease-free survival were compared between groups. RESULTS: Group B had significantly more SPM developed rate (p = 0.002), more SPM patients with advanced stage of FPM (p = 0.001), synchronous SPM (p = 0.006), and shorter SPM interval (p<0.001) compared to Group A. The survival rate in Group B was not significantly better than Group A. CONCLUSION: Among patients diagnosed with HNSCC recently, more SPMs are diagnosed in a shorter time interval and in a more advanced stage. The overall advances in diagnostic tools cannot significantly improve SPM survival, however, it enables more patients to receive corresponding treatment.
format Online
Article
Text
id pubmed-8846538
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-88465382022-02-16 Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools Wang, Shih-Wei Chan, Leong-Perng Wang, Ling-Feng Wu, Che-Wei Lin, Sheng-Hsuan Huang, Tzu-Yen Lee, Ka-Wo PLoS One Research Article BACKGROUND: The survival rate of head and neck squamous cell carcinoma (HNSCC) patients with secondary primary malignancy (SPM) showed no significant improvement for decades, however, the impact of advances in diagnostic tools is rarely mentioned. This study investigated the clinical characteristic of HNSCC with SPM over a 27-year period especially from the perspective of diagnostic tools. METHODS: This study evaluated 157 HNSCC patients with SPM. The patients were divided into two groups according to the time of SPM diagnosis (Group A:1992–2003; Group B: 2004–2014). Age, gender, stage of first primary malignancy (FPM), SPM interval, overall survival, and disease-free survival were compared between groups. RESULTS: Group B had significantly more SPM developed rate (p = 0.002), more SPM patients with advanced stage of FPM (p = 0.001), synchronous SPM (p = 0.006), and shorter SPM interval (p<0.001) compared to Group A. The survival rate in Group B was not significantly better than Group A. CONCLUSION: Among patients diagnosed with HNSCC recently, more SPMs are diagnosed in a shorter time interval and in a more advanced stage. The overall advances in diagnostic tools cannot significantly improve SPM survival, however, it enables more patients to receive corresponding treatment. Public Library of Science 2022-02-15 /pmc/articles/PMC8846538/ /pubmed/35167611 http://dx.doi.org/10.1371/journal.pone.0263773 Text en © 2022 Wang et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Wang, Shih-Wei
Chan, Leong-Perng
Wang, Ling-Feng
Wu, Che-Wei
Lin, Sheng-Hsuan
Huang, Tzu-Yen
Lee, Ka-Wo
Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools
title Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools
title_full Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools
title_fullStr Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools
title_full_unstemmed Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools
title_short Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools
title_sort secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846538/
https://www.ncbi.nlm.nih.gov/pubmed/35167611
http://dx.doi.org/10.1371/journal.pone.0263773
work_keys_str_mv AT wangshihwei secondaryprimarymalignancyinpatientswithheadandnecksquamouscellcarcinoma27yearexperiencefromtheperspectiveofdiagnostictools
AT chanleongperng secondaryprimarymalignancyinpatientswithheadandnecksquamouscellcarcinoma27yearexperiencefromtheperspectiveofdiagnostictools
AT wanglingfeng secondaryprimarymalignancyinpatientswithheadandnecksquamouscellcarcinoma27yearexperiencefromtheperspectiveofdiagnostictools
AT wuchewei secondaryprimarymalignancyinpatientswithheadandnecksquamouscellcarcinoma27yearexperiencefromtheperspectiveofdiagnostictools
AT linshenghsuan secondaryprimarymalignancyinpatientswithheadandnecksquamouscellcarcinoma27yearexperiencefromtheperspectiveofdiagnostictools
AT huangtzuyen secondaryprimarymalignancyinpatientswithheadandnecksquamouscellcarcinoma27yearexperiencefromtheperspectiveofdiagnostictools
AT leekawo secondaryprimarymalignancyinpatientswithheadandnecksquamouscellcarcinoma27yearexperiencefromtheperspectiveofdiagnostictools